These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27349273)

  • 1. Outcome of the Diffuse Sclerosing Variant of Papillary Thyroid Cancer: A Meta-Analysis.
    Malandrino P; Russo M; Regalbuto C; Pellegriti G; Moleti M; Caff A; Squatrito S; Vigneri R
    Thyroid; 2016 Sep; 26(9):1285-92. PubMed ID: 27349273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tall cell and diffuse sclerosing variants of papillary thyroid cancer: outcome and predicting value of risk stratification methods.
    Russo M; Malandrino P; Moleti M; Vermiglio F; Violi MA; Marturano I; Minaldi E; Vigneri R; Pellegriti G; Regalbuto C
    J Endocrinol Invest; 2017 Nov; 40(11):1235-1241. PubMed ID: 28528434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic importance of sclerosing variant in papillary thyroid carcinoma.
    Falvo L; Giacomelli L; D'Andrea V; Marzullo A; Guerriero G; de Antoni E
    Am Surg; 2006 May; 72(5):438-44. PubMed ID: 16719201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A diffuse sclerosing variant of papillary thyroid carcinoma: clinical and pathologic features and outcomes of 34 consecutive cases.
    Regalbuto C; Malandrino P; Tumminia A; Le Moli R; Vigneri R; Pezzino V
    Thyroid; 2011 Apr; 21(4):383-9. PubMed ID: 21309722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
    Kazaure HS; Roman SA; Sosa JA
    Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse sclerosing variant papillary thyroid carcinoma has worse survival than classic papillary thyroid carcinoma: a meta-analysis.
    Crayton H; Wu K; Leong D; Bhimani N; Gild M; Glover A
    Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36952650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between recurrence and age in the diffuse sclerosing variant of papillary thyroid carcinoma: clinical significance in pediatric patients.
    Kim J; Koo JS; Bang JI; Kim JK; Kang SW; Jeong JJ; Nam KH; Chung WY
    Front Endocrinol (Lausanne); 2024; 15():1359875. PubMed ID: 38966212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of aggressive variants of papillary thyroid carcinoma in patients under 55 years old: a SEER population-based retrospective analysis.
    Feng J; Shen F; Cai W; Gan X; Deng X; Xu B
    Endocrine; 2018 Sep; 61(3):499-505. PubMed ID: 29909599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma Is Associated With Aggressive Histopathological Features and a Poor Outcome: Results of a Large Multicentric Study.
    Chereau N; Giudicelli X; Pattou F; Lifante JC; Triponez F; Mirallié E; Goudet P; Brunaud L; Trésallet C; Tissier F; Leenhardt L; du Montcel ST; Menegaux F
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4603-4610. PubMed ID: 27626975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features and outcomes in patients with diffuse sclerosing variant of papillary thyroid carcinoma.
    Akaishi J; Sugino K; Kameyama K; Masaki C; Matsuzu K; Suzuki A; Uruno T; Ohkuwa K; Shibuya H; Kitagawa W; Nagahama M; Shimizu K; Ito K
    World J Surg; 2015 Jul; 39(7):1728-35. PubMed ID: 25743484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases.
    Thompson LD; Wieneke JA; Heffess CS
    Endocr Pathol; 2005; 16(4):331-48. PubMed ID: 16627920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of diffuse sclerosing variant papillary thyroid carcinoma: a systematic review and meta-analysis.
    Vuong HG; Kondo T; Pham TQ; Oishi N; Mochizuki K; Nakazawa T; Hassell L; Katoh R
    Eur J Endocrinol; 2017 Apr; 176(4):433-441. PubMed ID: 28183787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic characteristics and prognosis of diffuse sclerosing variant of papillary thyroid carcinoma in Japan: an 18-year experience at a single institution.
    Fukushima M; Ito Y; Hirokawa M; Akasu H; Shimizu K; Miyauchi A
    World J Surg; 2009 May; 33(5):958-62. PubMed ID: 19198928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Incidence of Distant Metastasis Is Associated With Histopathological Subtype of Pediatric Papillary Thyroid Cancer - a Retrospective Analysis Based on SEER.
    Zeng X; Wang Z; Gui Z; Xiang J; Cao M; Sun W; He L; Dong W; Huang J; Zhang D; Lv C; Zhang T; Shao L; Zhang P; Zhang H
    Front Endocrinol (Lausanne); 2021; 12():760901. PubMed ID: 34858334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse intrathyroidal dissemination of papillary thyroid carcinoma with no stromal fibrosis at presentation: A pattern of aggressive differentiated thyroid carcinoma.
    Fang H; Si Y; Wang C; Gong Q; Liu C; Wang S
    Pathol Res Pract; 2021 Aug; 224():153510. PubMed ID: 34329840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution.
    Lam AK; Lo CY
    Ann Surg Oncol; 2006 Feb; 13(2):176-81. PubMed ID: 16411146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of decoy receptor 3 in diffuse sclerosing variant of papillary thyroid carcinoma: correlation with M2 macrophage differentiation and lymphatic invasion.
    Chang WC; Chen JY; Lee CH; Yang AH
    Thyroid; 2013 Jun; 23(6):720-6. PubMed ID: 23186064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classic papillary thyroid carcinoma?
    Song E; Jeon MJ; Oh HS; Han M; Lee YM; Kim TY; Chung KW; Kim WB; Shong YK; Song DE; Kim WG
    Eur J Endocrinol; 2018 Sep; 179(3):135-142. PubMed ID: 29875289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcomes of Diffuse Sclerosing Variant Papillary Thyroid Carcinoma in Pediatric Patients.
    Brady C; Manning SC; Rudzinski E; Paulson V; Wang X; Liu YJ; Parikh SR; Bonilla-Velez J; Hawkins DS; Dahl J
    Laryngoscope; 2022 May; 132(5):1132-1138. PubMed ID: 34713899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse sclerosing variant of papillary thyroid carcinoma. A clinicopathologic study of 10 cases.
    Soares J; Limbert E; Sobrinho-Simões M
    Pathol Res Pract; 1989 Aug; 185(2):200-6. PubMed ID: 2798220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.